CDMO News Lonza Expands DNA-to-IND Offering to Bispecific Antibodies and Other Biologics 15 October 2026
CDMO News Recipharm Partners With CanVirex to Scale Oncolytic Measles Virus Manufacturing 24 September 2026
CDMO News Bachem to Invest More Than CHF 500 Million(US$620M) in Sisslerfeld Manufacturing Site 24 July 2026
CDMO News Lonza Licenses ADC Technology Platform to Engitix for Next-Generation Therapies 22 July 2026